Imunon, Inc. — Director's Dealing 2023

Dec 11, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2023-12-07

Reporting Person: Hazard Sebastien (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-07	Common Stock	A	20000	—	Acquired	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-07	Stock Option (Right to Buy)	$0.88	A	80000	Acquired	2033-12-11	Common Stock (80000)	Direct

Footnotes

F1: Represents grant of restricted stock, which vests on December 11, 2024.

F2: Represents grant of stock option, which vests with respect to 25% of the shares on December 11, 2024, and the remaining 75% in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable on the fourth anniversary of December 11, 2023.